Vision Science Benchmark Report 2025
Executive insights for Vision Science R&D, product, and engineering teams
Vision Science companies are investing in new ophthalmic products, diagnostic tools, platforms, and clinical technologies. But many teams still face the same challenge: moving from ideas, prototypes, and internal innovation efforts into scalable, validated, and clinically useful products.
The 2025 Vision Innovation Benchmark Report helps Vision Science leaders understand where the industry is investing, where innovation gets stuck, and what teams should prioritize in 2026.
Based on insights from
102 Industry Leaders
This report is based on insights from 102 executives and senior leaders across Vision Science, ophthalmology, diagnostics, medtech, and healthcare technology.
It captures how industry leaders are thinking about:
- Innovation investment priorities
- Product-readiness gaps
- R&D execution challenges
- Validation and clinical workflow fit
- Collaboration models
- Capabilities needed for 2026 and beyond
Who this report is for
This report is designed for teams and leaders working across
- Vision Science and ophthalmology
- Eye-care diagnostics and ophthalmic devices
- MedTech and healthcare technology
- Product development and platform teams
- R&D, innovation, and clinical technology groups
- Engineering teams building scalable healthcare products
It is especially useful for
- R&D leaders planning future innovation priorities
- Product teams moving concepts toward product readiness
- Engineering teams building scalable, clinical-grade systems
- Executives deciding where to invest next
What you will learn?
Download the report to understand
- Where Vision Science companies are investing today
- Why promising ideas often get stuck before becoming scalable products
- What R&D and product teams should prioritize in 2026